C. Michalski

A qualitative and quantitative analysis of von Willebrand factor contained in a very high‐purity plasma‐derived FVIII concentrate

B. Samor, C. Michalski, M. Brandin, 2012, Vox sanguinis.

Development of an enzyme-linked immunosorbent assay for human plasma inter-alpha-trypsin inhibitor (ITI) using specific antibodies against each of the H1 and H2 heavy chains.

C. Michalski, M. Balduyck, T. Burnouf, 1996, Journal of immunological methods.

Preparation and Properties of a Therapeutic Inter‐Alpha‐Trypsin Inhibitor Concentrate from Human Plasma

C. Michalski, J. Huart, M. Balduyck, 1994, Vox sanguinis.

Chondroitin sulphate covalently cross-links the three polypeptide chains of inter-alpha-trypsin inhibitor.

P. Sautière, C. Michalski, W. Morelle, 1994, European journal of biochemistry.

Large‐Scale Production and Properties of a Solvent‐Detergent‐Treated Factor IX Concentrate from Human Plasma

C. Michalski, M. Goudemand, T. Burnouf, 1988, Vox sanguinis.

Properties of a Highly Punified Human Plasma Factor IX:c Therapeutic Concentrate Prepared by Conventional Chromatography

C. Michalski, J. Huart, M. Goudemand, 1989, Vox sanguinis.

Efficacy and safety of continuous infusion of factor VII concentrate in a factor VII-deficient patient at high risk for arterial thrombosis.

C. Michalski, L. Drouet, J. Kevorkian, 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Human leucocyte elastase (HLE) preferentially cleaves the heavy chain H2 of inter-alpha-trypsin inhibitor (ITI).

B. Gressier, C. Michalski, P. Maes, 1993, Biological chemistry Hoppe-Seyler.